Long-Term Persistency and Costs Associated With the Use of Iron Chelation Therapies in the Treatment of Sickle Cell Disease Within Medicaid Programs
Journal of Medical Economics - United Kingdom
doi 10.3111/13696998.2012.723081
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 5, 2012
Authors
Publisher
Informa Healthcare